Abstract
Various methods for the direct reprogramming of human somatic cells have been developed. However, a therapeutic method to reprogram and eliminate human solid tumor cells has not been developed. Here we show a novel therapeutic method to reprogram and eliminate human solid tumor cells with chemicals. This therapeutic method may be applicable to various human solid tumor cells that express aldo-keto reductase family 1 member B10 (AKR1B10) and retinoid X receptors (RXRs).
Highlights
RETRACTION: A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals
The authors cannot guarantee the accuracy of the results and conclusions described in this article and wish to retract it
Hisashi Moriguchi’s affiliation is incorrect. He is affiliated with University of Tokyo but not with Massachusetts General Hospital nor with Harvard Medical School
Summary
RETRACTION: A therapeutic method for the direct reprogramming of human liver cancer cells with only chemicals.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
